![Christian Kjellman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christian Kjellman
Plus aucun poste en cours
Profil
Christian Kjellman worked as a Senior Scientist at BioInvent International AB, Head-Research at Cartela AB, and Assistant Professor at the University of Lund.
He is currently the Chief Operating Officer & Senior Vice President at Hansa Biopharma AB.
Dr. Kjellman holds a graduate degree from the University of Lund and a doctorate degree conferred in 1999.
Anciens postes connus de Christian Kjellman
Sociétés | Poste | Fin |
---|---|---|
HANSA BIOPHARMA AB | Directeur des opérations | 01/02/2023 |
BIOINVENT INTERNATIONAL AB | Corporate Officer/Principal | - |
University of Lund | Corporate Officer/Principal | - |
Cartela AB
![]() Cartela AB Pharmaceuticals: MajorHealth Technology Cartela AB develops therapies for arthritic diseases. It products are mainly used by osteoarthritis and rheumatoid arthritis. Its business is based on the cell surface molecules, integrants a10ß1 and a11ß1. The company was founded by Evy Lundgren-Åkerlund and Donald Gullberg in 2000 and is headquartered in Lund, Sweden. | Directeur Technique/Scientifique/R&D | - |
Formation de Christian Kjellman
University of Lund | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
HANSA BIOPHARMA AB | Health Technology |
BIOINVENT INTERNATIONAL AB | Health Technology |
Entreprise privées | 1 |
---|---|
Cartela AB
![]() Cartela AB Pharmaceuticals: MajorHealth Technology Cartela AB develops therapies for arthritic diseases. It products are mainly used by osteoarthritis and rheumatoid arthritis. Its business is based on the cell surface molecules, integrants a10ß1 and a11ß1. The company was founded by Evy Lundgren-Åkerlund and Donald Gullberg in 2000 and is headquartered in Lund, Sweden. | Health Technology |